Cargando…
Safety and immunogenicity of Salmonella typhimurium expressing C-terminal truncated human IL-2 in a murine model
Salmonella enterica serovar Typhimurium preferentially colonizes tumors in vivo and has proven to be an effective biologic vector. The attenuated S. enterica Typhimurium strain χ4550 was engineered to express truncated human interleukin-2 and renamed SalpIL2. Previously, we observed that a single or...
Autores principales: | Sorenson, Brent, Banton, Kaysie, Augustin, Lance, Barnett, Sean, McCulloch, Karen, Dorn, Joshua, Frykman, Natalie, Leonard, Arnold, Saltzman, Daniel |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846145/ https://www.ncbi.nlm.nih.gov/pubmed/20376175 |
Ejemplares similares
-
Antioxidant oils and Salmonella enterica Typhimurium reduce tumor in an experimental model of hepatic metastasis
por: Sorenson, Brent S, et al.
Publicado: (2011) -
A Phase I, Dose Escalation, Single Dose Trial of Oral Attenuated Salmonella typhimurium Containing Human IL-2 in Patients With Metastatic Gastrointestinal Cancers
por: Gniadek, Thomas J., et al.
Publicado: (2020) -
Immunogenicity and Cross-Protective Efficacy Induced by Outer Membrane Proteins from Salmonella Typhimurium Mutants with Truncated LPS in Mice
por: Liu, Qiong, et al.
Publicado: (2016) -
Immunogenic potential of a Salmonella Typhimurium live vaccine for pigs against monophasic Salmonella Typhimurium DT 193
por: Theuß, Tobias, et al.
Publicado: (2017) -
Immunogenicity of a Bivalent Adjuvanted Glycoconjugate Vaccine against Salmonella Typhimurium and Salmonella Enteritidis
por: Fiorino, Fabio, et al.
Publicado: (2017)